Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011286122> ?p ?o ?g. }
- W3011286122 abstract "9144 Background: NCI PRO-CTCAE is designed to enhance adverse event reporting by integrating patients’ self-report of the frequency (F), severity (S) and interference (I) with usual activities of 78 symptomatic treatment toxicities. This study examined the construct validity of a subset of PRO-CTCAE items in women with metastatic breast cancer (MBC). Methods: 207 women (70% aged 45-59 years; 94% White;71% college-educated) with HER2+ MBC who had received treatment in the past month were recruited from 6 U.S. breast cancer support groups and completed a web survey that collected 18 PRO-CTCAE symptoms, and the Rotterdam Symptom Checklist (RSC). Pairwise concordance among PRO-CTCAE symptom dimensions was examined using weighted Kappa and Bowker’s test for symmetry. Results: Respondents were a median of 47 months since MBC diagnosis and 61% rated their health-related quality of life (HRQL) as good to excellent. Symptom prevalence was similar for PRO-CTCAE and RSC, with respondents more likely to endorse mood disturbance on PRO-CTCAE (Anxiety/Worry 90%; Sad/Unhappy Feelings 86%) vs. RSC (Anxiety 63%; Depressed Mood 61%). There was parallel rank-ordering of fatigue, anxiety, insomnia, depression, difficulty concentrating and neuropathy as the symptoms that were most severe, interfered most and caused the greatest bother. Within PRO-CTCAE, pairwise agreement among F, S and I was moderate for most symptoms (κ w =.42 to .54). Agreement between F and S was highest for pain, nausea and arm/leg swelling (κ w =.61 to .80), and lowest for anxiety/worry and sad/unhappy feelings (κ w = .27-.37). Except for arm/leg swelling, endorsement patterns by the dimensions of F, S and I were distinct (Bowker’s p all <.002). Across PRO-CTCAE symptoms, S was consistently higher than I (mean differences .12 to .72, all p<.01]). Means for S were consistently and significantly higher for those with impaired versus preserved HRQL, providing evidence of construct validity. Conclusions: This study supports the construct validity of PRO-CTCAE, and suggests that F, S and I dimensions offer non-overlapping information relative to 17 /18 PRO-CTCAE symptomatic toxicities." @default.
- W3011286122 created "2020-03-23" @default.
- W3011286122 creator A5009586235 @default.
- W3011286122 creator A5013638977 @default.
- W3011286122 creator A5016587367 @default.
- W3011286122 creator A5018456847 @default.
- W3011286122 creator A5021287787 @default.
- W3011286122 creator A5023674071 @default.
- W3011286122 creator A5029672774 @default.
- W3011286122 creator A5037416583 @default.
- W3011286122 creator A5042150016 @default.
- W3011286122 creator A5043812704 @default.
- W3011286122 creator A5045265283 @default.
- W3011286122 creator A5046042179 @default.
- W3011286122 creator A5050639550 @default.
- W3011286122 creator A5050802768 @default.
- W3011286122 creator A5068059897 @default.
- W3011286122 creator A5068781080 @default.
- W3011286122 creator A5069643040 @default.
- W3011286122 creator A5072015843 @default.
- W3011286122 creator A5091400921 @default.
- W3011286122 date "2012-05-20" @default.
- W3011286122 modified "2023-09-27" @default.
- W3011286122 title "Validation of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women receiving treatment for metastatic breast cancer." @default.
- W3011286122 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.9144" @default.
- W3011286122 hasPublicationYear "2012" @default.
- W3011286122 type Work @default.
- W3011286122 sameAs 3011286122 @default.
- W3011286122 citedByCount "1" @default.
- W3011286122 countsByYear W30112861222021 @default.
- W3011286122 crossrefType "journal-article" @default.
- W3011286122 hasAuthorship W3011286122A5009586235 @default.
- W3011286122 hasAuthorship W3011286122A5013638977 @default.
- W3011286122 hasAuthorship W3011286122A5016587367 @default.
- W3011286122 hasAuthorship W3011286122A5018456847 @default.
- W3011286122 hasAuthorship W3011286122A5021287787 @default.
- W3011286122 hasAuthorship W3011286122A5023674071 @default.
- W3011286122 hasAuthorship W3011286122A5029672774 @default.
- W3011286122 hasAuthorship W3011286122A5037416583 @default.
- W3011286122 hasAuthorship W3011286122A5042150016 @default.
- W3011286122 hasAuthorship W3011286122A5043812704 @default.
- W3011286122 hasAuthorship W3011286122A5045265283 @default.
- W3011286122 hasAuthorship W3011286122A5046042179 @default.
- W3011286122 hasAuthorship W3011286122A5050639550 @default.
- W3011286122 hasAuthorship W3011286122A5050802768 @default.
- W3011286122 hasAuthorship W3011286122A5068059897 @default.
- W3011286122 hasAuthorship W3011286122A5068781080 @default.
- W3011286122 hasAuthorship W3011286122A5069643040 @default.
- W3011286122 hasAuthorship W3011286122A5072015843 @default.
- W3011286122 hasAuthorship W3011286122A5091400921 @default.
- W3011286122 hasConcept C121608353 @default.
- W3011286122 hasConcept C126322002 @default.
- W3011286122 hasConcept C138885662 @default.
- W3011286122 hasConcept C143998085 @default.
- W3011286122 hasConcept C177713679 @default.
- W3011286122 hasConcept C197934379 @default.
- W3011286122 hasConcept C2775930923 @default.
- W3011286122 hasConcept C2777793932 @default.
- W3011286122 hasConcept C41895202 @default.
- W3011286122 hasConcept C530470458 @default.
- W3011286122 hasConcept C547195049 @default.
- W3011286122 hasConcept C71924100 @default.
- W3011286122 hasConceptScore W3011286122C121608353 @default.
- W3011286122 hasConceptScore W3011286122C126322002 @default.
- W3011286122 hasConceptScore W3011286122C138885662 @default.
- W3011286122 hasConceptScore W3011286122C143998085 @default.
- W3011286122 hasConceptScore W3011286122C177713679 @default.
- W3011286122 hasConceptScore W3011286122C197934379 @default.
- W3011286122 hasConceptScore W3011286122C2775930923 @default.
- W3011286122 hasConceptScore W3011286122C2777793932 @default.
- W3011286122 hasConceptScore W3011286122C41895202 @default.
- W3011286122 hasConceptScore W3011286122C530470458 @default.
- W3011286122 hasConceptScore W3011286122C547195049 @default.
- W3011286122 hasConceptScore W3011286122C71924100 @default.
- W3011286122 hasLocation W30112861221 @default.
- W3011286122 hasOpenAccess W3011286122 @default.
- W3011286122 hasPrimaryLocation W30112861221 @default.
- W3011286122 hasRelatedWork W1916420922 @default.
- W3011286122 hasRelatedWork W2148745820 @default.
- W3011286122 hasRelatedWork W2248501232 @default.
- W3011286122 hasRelatedWork W2467921172 @default.
- W3011286122 hasRelatedWork W2616873123 @default.
- W3011286122 hasRelatedWork W2626651315 @default.
- W3011286122 hasRelatedWork W2786885189 @default.
- W3011286122 hasRelatedWork W2794705429 @default.
- W3011286122 hasRelatedWork W2899105859 @default.
- W3011286122 hasRelatedWork W2912048221 @default.
- W3011286122 hasRelatedWork W2937237711 @default.
- W3011286122 hasRelatedWork W2966058518 @default.
- W3011286122 hasRelatedWork W2969976004 @default.
- W3011286122 hasRelatedWork W2975834093 @default.
- W3011286122 hasRelatedWork W2981027251 @default.
- W3011286122 hasRelatedWork W3030016402 @default.
- W3011286122 hasRelatedWork W3091954714 @default.
- W3011286122 hasRelatedWork W3094093887 @default.
- W3011286122 hasRelatedWork W3205127230 @default.
- W3011286122 hasRelatedWork W3093831117 @default.
- W3011286122 isParatext "false" @default.
- W3011286122 isRetracted "false" @default.
- W3011286122 magId "3011286122" @default.